Skip to main content
. 2016 Jul 6;14(3):1923–1932. doi: 10.3892/mmr.2016.5474

Figure 3.

Figure 3

LOXL2 silencing decreased proliferation of hepatocellular carcinoma cells. (A) The number of cells and fold change in proliferation in HepG2 cells. (B) The number of cells and fold increase in proliferation in SMMC-7721 cells. LOXL2, lysyl oxidase-like 2; siRNA, small interfering RNA.